Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States
Authors:
- Edward P. RothsteinEREdward P. Rothstein
- Pennridge Pediatric AssociatesPAPennridge Pediatric Associates
- Michael E. PichicheroMPMichael E. Pichichero
- John L. GreenJGJohn L. Green
- Elmwood PediatricsEPElmwood Pediatrics
- Keith S. ReisingerKRKeith S. Reisinger
- Mark M. BlatterMBMark M. Blatter
- Judith HalpernJHJudith Halpern
- Allan M. ArbeterAAAllan M. Arbeter
- David I. BernsteinDBDavid I. Bernstein
- Vicki SmithVSVicki Smith
Open Access
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old childrenThe Pediatric Infectious Disease Journal, 1994
- Primum non nocereThe Pediatric Infectious Disease Journal, 1993
- Acellular Pertussis Vaccines--A Solution to the Pertussis ProblemThe Journal of Infectious Diseases, 1993
- Acellular Pertussis Vaccines—A Solution to the Pertussis Problem?The Journal of Infectious Diseases, 1993
- Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccinesThe Journal of Pediatrics, 1992
- Acellular Pertussis Vaccines: Recommendations for Use as the Fourth and Fifth DosesPediatrics, 1992
- Efficacy of Whole-Cell Pertussis Vaccine in Preschool Children in the United StatesJAMA, 1992
- Pertussis: the trials and tribulations of old and new pertussis vaccinesVaccine, 1992
- Report of the Task Force on Pertussis and Pertussis Immunization—1988Pediatrics, 1988
- Statistical considerations in the quantitation of serum immunoglobulin levels using the Enzyme-Linked Immunosorbent Assay (ELISA)Journal of Immunological Methods, 1987